PCMI
Paradigm Capital Management Inc Portfolio holdings
AUM
$2.05B
This Quarter Return
+21.32%
1 Year Return
+12.74%
3 Year Return
+134.07%
5 Year Return
+283.66%
10 Year Return
+799.95%
AUM
$2.05B
AUM Growth
+$2.05B
(+14%)
Cap. Flow
-$11.1M
Cap. Flow
% of AUM
-0.54%
Top 10 Holdings %
Top 10 Hldgs %
55.42%
Holding
131
New
4
Increased
20
Reduced
45
Closed
9
Top Buys
| 1 |
Owens & Minor
OMI
|
$17.5M |
| 2 |
Enovis
ENOV
|
$10.3M |
| 3 |
Integra LifeSciences
IART
|
$9.77M |
| 4 |
Orthofix Medical
OFIX
|
$9.58M |
| 5 |
Zumiez
ZUMZ
|
$8.43M |
Top Sells
| 1 |
American Woodmark
AMWD
|
$18M |
| 2 |
SI-BONE Inc
SIBN
|
$11.4M |
| 3 |
Semtech
SMTC
|
$6.59M |
| 4 |
Axcelis
ACLS
|
$6.55M |
| 5 |
Nature's Sunshine
NATR
|
$5.68M |
Sector Composition
| 1 | Technology | 57.31% |
| 2 | Healthcare | 18.92% |
| 3 | Industrials | 12.43% |
| 4 | Consumer Discretionary | 10.17% |
| 5 | Materials | 0.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Halozyme
HALO
$8.56B
| $520K | 0.03% |
10,000
| – | – |
|
102
Ichor Holdings
ICHR
$566M
| $511K | 0.02% |
+26,000
| New | +$511K |
|
103
Hillenbrand
HI
$1.79B
| $468K | 0.02% |
23,300
| – | – |
|
104
Gentherm
THRM
$1.12B
| $424K | 0.02% |
15,000
| – | – |
|
105
Procter & Gamble
PG
$370B
| $398K | 0.02% |
2,500
-500
| -17% | -$79.7K |
|
106
Primoris Services
PRIM
$6.27B
| $390K | 0.02% |
5,000
| – | – |
|
107
TELA Bio
TELA
$70.5M
| $388K | 0.02% |
200,000
| – | – |
|
108
Banner Corp
BANR
$2.32B
| $385K | 0.02% |
6,000
| – | – |
|
109
Applied Materials
AMAT
$126B
| $366K | 0.02% |
2,000
| – | – |
|
110
Edwards Lifesciences
EW
$47.8B
| $344K | 0.02% |
4,400
-2,100
| -32% | -$164K |
|
111
National Bank Holdings
NBHC
$1.49B
| $338K | 0.02% |
9,000
| – | – |
|
112
Fidelity National Financial
FNF
$16.3B
| $331K | 0.02% |
5,900
| – | – |
|
113
Pfizer
PFE
$142B
| $276K | 0.01% |
11,400
-5,600
| -33% | -$136K |
|
114
Nova
NVMI
$6.97B
| $275K | 0.01% |
+1,000
| New | +$275K |
|
115
Ziff Davis
ZD
$1.57B
| $253K | 0.01% |
8,350
| – | – |
|
116
Neogen
NEOG
$1.25B
| $249K | 0.01% |
52,000
-205,100
| -80% | -$980K |
|
117
Harrow
HROW
$1.4B
| $244K | 0.01% |
8,000
| – | – |
|
118
Bristol-Myers Squibb
BMY
$96.5B
| $236K | 0.01% |
5,100
-5,000
| -50% | -$231K |
|
119
Cambium Networks
CMBM
$19.2M
| $189K | 0.01% |
466,900
-1,500
| -0.3% | -$608 |
|
120
Lakeland Industries
LAKE
$145M
| $136K | 0.01% |
+10,000
| New | +$136K |
|
121
Codexis
CDXS
$227M
| $122K | 0.01% |
50,000
| – | – |
|
122
Standard BioTools
LAB
$474M
| $20.9K | ﹤0.01% |
17,457
-230,943
| -93% | -$277K |
|
123
Build-A-Bear
BBW
$803M
| – | – |
-10,000
| Closed | -$372K |
|
124
CDW
CDW
$21.6B
| – | – |
-3,000
| Closed | -$481K |
|
125
Citi Trends
CTRN
$296M
| – | – |
-107,028
| Closed | -$2.37M |
|